---
title: "当前购买诺和诺德公司股票的三个理由"
description: "制药行业的领军者正在逐步为强劲反弹奠定基础"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/258887879.md"
published_at: "2025-09-25T12:37:14.000Z"
---

# 当前购买诺和诺德公司股票的三个理由

> 制药行业的领军者正在逐步为强劲反弹奠定基础

The pharmaceutical leader is gradually laying the groundwork for a strong rebound.

### Related Stocks

- [NVO.US - 诺和诺德公司](https://longbridge.com/zh-CN/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Novo Nordisk CFO Karsten Munk Knudsen Sells Shares Worth Over DKK 8.3 Million | Novo Nordisk A/S announced that CFO Karsten Munk Knudsen sold 26,246 shares for DKK 8.3 million at DKK 315.60 each and 3 | [Link](https://longbridge.com/zh-CN/news/275652909.md) |
| Novo Nordisk to Manufacture Wegovy in Ireland Facility | Novo Nordisk to Manufacture Wegovy in Ireland Facility | [Link](https://longbridge.com/zh-CN/news/275789396.md) |
| Savvy Advisors Inc. Purchases 22,138 Shares of Novo Nordisk A/S $NVO | Savvy Advisors Inc. increased its stake in Novo Nordisk A/S by 83.0% in Q3, acquiring 22,138 shares, bringing its total  | [Link](https://longbridge.com/zh-CN/news/275761183.md) |
| Oppenheimer Asset Management Inc. Has $31.35 Million Stock Position in Novo Nordisk A/S $NVO | Oppenheimer Asset Management Inc. increased its stake in Novo Nordisk A/S by 14.4% in Q3, holding 565,007 shares valued  | [Link](https://longbridge.com/zh-CN/news/275287765.md) |
| Novo set to make Wegovy pill in Ireland for markets outside US - Bloomberg News | Novo set to make Wegovy pill in Ireland for markets outside US - Bloomberg News | [Link](https://longbridge.com/zh-CN/news/275772102.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。
